Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-001982
Filing Date
2012-08-10
Accepted
2012-08-09 18:00:09
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 AMEXDRUG CORPORATION 10Q 2012-06-30 amexdrug10q.htm 10-Q 482833
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrugexh311.htm EX-31.1 14015
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrugexh312.htm EX-31.2 14011
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES amexdrugexh321.htm EX-32.1 6598
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES amexdrugexh322.htm EX-32.2 6863
  Complete submission text file 0001096906-12-001982.txt   1320294

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axrx-20120630.xml EX-101.INS 53976
7 XBRL TAXONOMY EXTENSION axrx-20120630.xsd EX-101.SCH 11202
8 XBRL TAXONOMY EXTENSION axrx-20120630_cal.xml EX-101.CAL 4780
9 XBRL TAXONOMY EXTENSION axrx-20120630_def.xml EX-101.DEF 50251
10 XBRL TAXONOMY EXTENSION axrx-20120630_lab.xml EX-101.LAB 89011
11 XBRL TAXONOMY EXTENSION axrx-20120630_pre.xml EX-101.PRE 63330
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

EIN.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10304 | Film No.: 121021814
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries